Overview
- 29 inspections across 27 sites are on record.
- 98 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-03-28.
At a glance
Inspections
29
Sites
27
Observations
98
Career since
Jun 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Wells Pharma of Houston LLC | 28 Mar 2025 | Human Drugs | On file |
| Revive Rx LLC dba Revive Rx Pharmacy | 7 Feb 2025 | Human Drugs | On file |
| SCA Pharmaceuticals, LLC | 20 Dec 2024 | Human Drugs | On file |
| OSRX Inc. | 25 Oct 2024 | Human Drugs | On file |
| Pine Pharmaceuticals, LLC | 30 Sep 2024 | Human Drugs | On file |
Sites inspected
Wells Pharma of Houston LLCHouston, United States1 insp.
Revive Rx LLC dba Revive Rx PharmacyHouston, United States1 insp.
SCA Pharmaceuticals, LLCWindsor, United States1 insp.
OSRX Inc.Missoula, United States1 insp.
Pine Pharmaceuticals, LLCTonawanda, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Pamela N Agaba2 shared
Amy N Chen2 shared
Lauren H Augustyniak1 shared
Christian F Gomez Lugo1 shared
Karishma G Gopaul1 shared
Samir C Gala1 shared
Ekaterina Allen1 shared
Simone E Pitts1 shared
Ucheabuchi C Chudi-Nwankwor1 shared
James R Birkenstamm1 shared
Full investigator report
Get the verbatim findings behind Jazmine N Brown's 98 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site